RESUMEN

Introduction: Speckle-tracking echocardiography has shown its usefulness in the evaluation of the right ventricle (RV) in healthy subjects and in pulmonary hypertension. It is unknown whether this technique could be sensitive to assess healthy RV with increases in preload. Methods: Consecutive subjects were studied without evidence of cardiopulmonary disease. They underwent speckle-tracking echocardiography in General Electric Vivid 7® equipment. The "segmental longitudinal strain" (SLS) and "global longitudinal strain" (GLS) of the RV was determined at rest and with an increase in the preload through elevation the legs to 45°. Results: We analyzed 31 subjects, 16 men and 15 women, aged 16-53 years, in which were measured SLS and GLS. Basal of the RV free wall: -29.1 ± 3.3 versus -32.7 ± 5.5%, p = 0.0002. Mid of the RV free wall: -28.6 ± 6.4 versus -31.5 ± 4.9 %, p = 0.001. Apical of the free wall of the RV: -21.9 ± 6.5 versus -23.3 ± 6.1 %, p = 0.118. Basal inferoseptum: -19.40 ± 3.2 versus -18.9 ± 3.0 %, p = 0.204. Mid inferoseptum: -19.3 ± 3.2 versus -19 ± 3.1 %, p = 0.249. Apical septum: -17.1 ± 5.1 versus -17 ± 5.4 %, p = 0.457. GLS of the RV: -23.06 ± 3.4 versus -24.5 ± 2.9 %, p = 0.002. ICC: 0.773, 95 % CI: 0.534-0.890, p < 0.001. Conclusions: This method was sensitive to detect differences in the GLS and SLS basal and mid of the RV free wall.

Introducción: La ecocardiografía speckle-tracking (EST) ha mostrado su utilidad en la evaluación del ventrículo derecho (VD) en sujetos sanos y en hipertensión pulmonar. Se desconoce si esta técnica es sensible para evaluar el VD en sujetos sanos con aumento en la precarga. Método: Se evaluaron sujetos consecutivos sin evidencia de enfermedad cardiopulmonar. Se realizó EST con equipo General Electric Vivid 7®. La deformación longitudinal segmentaria (DLS) y la deformación longitudinal global (DLG) del VD se determinaron en reposo y con incremento en la precarga mediante la elevación de las piernas a 45°. Resultados: Analizamos 31 sujetos, 16 hombres y 15 mujeres. Edad: 16-53 años. Basal de la pared libre del VD: ­29.1 ± 3.3 vs. ­32.7 ± 5.5%, p = 0.0002. Medio de la pared libre del VD: ­28.6 ± 6.4 vs. ­31.5 ± 4.9%, p = 0.001. Apical de la pared libre del VD: ­21.9 ± 6.5 vs. ­23.3 ± 6.1, p = 0.118. Basal septum inferior: ­19.40 ± 3.2 vs. ­18.9 ± 3.0%, p = 0.204. Medio septum inferior: ­19.3 ± 3.2 vs. ­19 ± 3.1%, p = 0.249. Apical septal −17.1% ± 5.1 vs. −17 ± 5.4, p = 0.457. DLG del VD: ­23.06 ± 3.4 vs. ­24.5 ± 2.9%, p = 0.002. CCI: 0.773, IC 95%: 0.534-0.890, p < 0.001. Conclusiones: El método fue sensible para detectar diferencias en la DLG y DLS basal y media de la pared libre del VD.

Asunto(s)

RESUMEN

Introduction: Speckle-tracking echocardiography has shown its usefulness in the evaluation of the right ventricle (RV) in healthy subjects and in pulmonary hypertension. It is unknown whether this technique could be sensitive to assess healthy RV with increases in preload. Methods: Consecutive subjects were studied without evidence of cardiopulmonary disease. They underwent speckle-tracking echocardiography in General Electric Vivid 7® equipment. The "segmental longitudinal strain" (SLS) and "global longitudinal strain" (GLS) of the RV was determined at rest and with an increase in the preload through elevation the legs to 45°. Results: We analyzed 31 subjects, 16 men and 15 women, aged 16-53 years, in which were measured SLS and GLS. Basal of the RV free wall: -29.1 ± 3.3 versus -32.7 ± 5.5%, p = 0.0002. Mid of the RV free wall: -28.6 ± 6.4 versus -31.5 ± 4.9%, p = 0.001. Apical of the free wall of the RV: -21.9 ± 6.5 versus -23.3 ± 6.1%, p = 0.118. Basal inferoseptum: -19.40 ± 3.2 versus -18.9 ± 3.0%, p = 0.204. Mid inferoseptum: -19.3 ± 3.2 versus -19 ± 3.1%, p = 0.249. Apical septum: -17.1 ± 5.1 versus -17 ± 5.4%, p = 0.457. GLS of the RV: -23.06 ± 3.4 versus -24.5 ± 2.9%, p = 0.002. ICC: 0.773, 95% CI: 0.534-0.890, p < 0.001. Conclusions: This method was sensitive to detect differences in the GLS and SLS basal and mid of the RV free wall.

Introducción y objetivos: La ecocardiografía speckle-tracking (EST) ha mostrado su utilidad en la evaluación del ventrículo derecho (VD) en sujetos sanos y en hipertensión pulmonar. Se desconoce si esta técnica es sensible para evaluar el VD en sujetos sanos con aumento en la precarga. Método: Se evaluaron sujetos consecutivos sin evidencia de enfermedad cardiopulmonar. Se realizó EST con equipo General Electric Vivid 7®. La deformación longitudinal segmentaria (DLS) y la deformación longitudinal global (DLG) del VD se determinaron en reposo y con incremento en la precarga mediante la elevación de las piernas a 45°. Resultados: Analizamos 31 sujetos, 16 hombres y 15 mujeres. Edad: 16-53 años. Basal de la pared libre del VD: ­29.1 ± 3.3 vs. ­32.7 ± 5.5%, p = 0.0002. Medio de la pared libre del VD: ­28.6 ± 6.4 vs. ­31.5 ± 4.9%, p = 0.001. Apical de la pared libre del VD: ­21.9 ± 6.5 vs. ­23.3 ± 6.1, p = 0.118. Basal septum inferior: ­19.40 ± 3.2 vs. ­18.9 ± 3.0%, p = 0.204. Medio septum inferior: ­19.3 ± 3.2 vs. ­19 ± 3.1%, p = 0.249. Apical septal −17.1% ± 5.1 vs. −17 ± 5.4, p = 0.457. DLG del VD: ­23.06 ± 3.4 vs. ­24.5 ± 2.9%, p = 0.002. CCI: 0.773, IC 95%: 0.534-0.890, p < 0.001. Conclusiones: El método fue sensible para detectar diferencias en la DLG y DLS basal y media de la pared libre del VD.

Asunto(s)

RESUMEN

Abstract Introduction: Speckle-tracking echocardiography has shown its usefulness in the evaluation of the right ventricle (RV) in healthy subjects and in pulmonary hypertension. It is unknown whether this technique could be sensitive to assess healthy RV with increases in preload. Methods: Consecutive subjects were studied without evidence of cardiopulmonary disease. They underwent speckle-tracking echocardiography in General Electric Vivid 7® equipment. The "segmental longitudinal strain" (SLS) and "global longitudinal strain" (GLS) of the RV was determined at rest and with an increase in the preload through elevation the legs to 45°. Results: We analyzed 31 subjects, 16 men and 15 women, aged 16-53 years, in which were measured SLS and GLS. Basal of the RV free wall: —29.1 ± 3.3 versus −32.7 ± 5.5%, p = 0.0002. Mid of the RV free wall: —28.6 ± 6.4 versus —31.5 ± 4.9 %, p = 0.001. Apical of the free wall of the RV: —21.9 ± 6.5 versus —23.3 ± 6.1 %, p = 0.118. Basal inferoseptum: —19.40 ± 3.2 versus —18.9 ± 3.0 %, p = 0.204. Mid inferoseptum: —19.3 ± 3.2 versus —19 ± 3.1 %, p = 0.249. Apical septum: —17.1 ± 5.1 versus —17 ± 5.4 %, p = 0.457. GLS of the RV: —23.06 ± 3.4 versus —24.5 ± 2.9 %, p = 0.002. ICC: 0.773, 95 % CI: 0.534-0.890, p < 0.001. Conclusions: This method was sensitive to detect differences in the GLS and SLS basal and mid of the RV free wall.

Resumen Introducción: La ecocardiografía speckle-tracking (EST) ha mostrado su utilidad en la evaluación del ventrículo derecho (VD) en sujetos sanos y en hipertensión pulmonar. Se desconoce si esta técnica es sensible para evaluar el VD en sujetos sanos con aumento en la precarga. Método: Se evaluaron sujetos consecutivos sin evidencia de enfermedad cardiopulmonar. Se realizó EST con equipo General Electric Vivid 7®. La deformación longitudinal segmentaria (DLS) y la deformación longitudinal global (DLG) del VD se determinaron en reposo y con incremento en la precarga mediante la elevación de las piernas a 45°. Resultados: Analizamos 31 sujetos, 16 hombres y 15 mujeres. Edad: 16-53 años. Basal de la pared libre del VD: —29.1 ± 3.3 vs. —32.7 ± 5.5%, p = 0.0002. Medio de la pared libre del VD: —28.6 ± 6.4 vs. —31.5 ± 4.9%, p = 0.001. Apical de la pared libre del VD: —21.9 ± 6.5 vs. —23.3 ± 6.1, p = 0.118. Basal septum inferior: —19.40 ± 3.2 vs. —18.9 ± 3.0%, p = 0.204. Medio septum inferior: —19.3 ± 3.2 vs. —19 ± 3.1%, p = 0.249. Apical septal −17.1% ± 5.1 vs. −17 ± 5.4, p = 0.457. DLG del VD: —23.06 ± 3.4 vs. —24.5 ± 2.9%, p = 0.002. CCI: 0.773, IC 95%: 0.534-0.890, p < 0.001. Conclusiones: El método fue sensible para detectar diferencias en la DLG y DLS basal y media de la pared libre del VD.

Asunto(s)

RESUMEN

Abstract: Objectives: To establish a relationship between global longitudinal strain (GLS) and Galectin-3 in pre-clinical heart failure in diabetic patients. Galectin-3 is a biomarker in heart failure with depressed ejection fraction (HFdEF). The hypothesis is presented that Galectin-3 is related to GLS and can detect left ventricular dysfunction in heart failure with preserved ejection fraction. Methods: Galectin-3 and GLS were measured in 121 asymptomatic individuals: 14 diabetics with mild depressed ejection fraction (mdEF) (LVEF 47.0 ± 6.9); 76 diabetics with preserved ejection fraction (LVEF 61 ± 5.5), and 31 controls (61.7 ± 5.1). Results: Galectin-3 was elevated in all diabetics vs controls (3.46 ± 1.36 ng/ml vs 2.78 ± 0.91 ng/ml; p = .003). It was also elevated in mdEF (3.76 ± 1.12 ng/ml vs 2.78 ± 0.9 ng/ml; p = .009) and pEF subjects (3.41 ± 1.40 ng/ml vs 2.78 ± 0.9 ng/ml; p = .058), respectively, vs controls. No difference in Gal-3 was found between diabetic groups (p = .603). Diabetics had lower GLS than controls (-18.5 ± 3.9 vs -20 ± 2.6; p = .022). Diabetics with mdEF had lower GLS than those with pEF (-13.3 ± 3.41 vs -19 ± 3.2; P<.001). There was no difference in GLS with pEF compared to controls (-19.4 ± 3.2 vs -20 ± 2.6; p = .70). Conclusions: Galectin-3 is elevated in diabetic patients with mdEF, and is associated with a diminished GLS. GLS could be an early marker of left ventricular dysfunction as well as evidence of diabetic cardiomyopathy.

Resumen: Objetivos: Establecer una asociación entre deformación longitudinal global (DLG) y galectina-3 en insuficiencia cardiaca preclínica en pacientes diabéticos. Galectina-3 es un biomarcador en insuficiencia cardiaca con fracción de eyección deprimida. Nuestra hipótesis es que la DLG y galectina-3 correlacionan y pueden detectar disfunción ventricular en insuficiencia cardiaca con FEVI preservada. Métodos: Se midieron galectina-3 y DLG en 121 individuos asintomáticos: 14 diabéticos con FEVI deprimida leve (FEdl) (FEVI 47 ± 6.9); 76 diabéticos con FEVI preservada (FEp) (FEVI 61 ± 5.5) y 31 sujetos controles (FEVI 61.7 ± 5.1). Resultados: Galectina-3 se encontró elevada en todos los diabéticos vs controles (3.46 ± 1.36 ng/ml vs 2.78 ± 0.91 ng/ml; p = 0.003). Está elevada en sujetos con FEdl (3.76 ± 1.12 vs 2.78 ± 0.9 vs ng/ml p = 0.009) y FEp (3.41 ± 1.40 vs 2.78 ± 0.9 ng/ml p = 0.058), respectivamente vs controles; no encontramos diferencia en galectina-3 en ambos grupos de diabéticos (p = 0.603). Los diabéticos tienen menor DLG que los controles (-18.5 ± 3.9 vs -20 ± 2.6; p = 0.022). Los diabéticos con FEdl tienen DLG más disminuida que aquellos con FEp (-13.3 ± 3.41 vs -19 ± 3.2; p < 0.001). No existe diferencia en DLG con FEp y controles (-19.4 ± 3.2 vs -20 ± 2.6; p = 0.70). Conclusiones: Galectina-3 está elevada en diabéticos con FEdl y correlaciona DLG disminuida. DLG podría ser un marcador temprano de disfunción ventricular y evidencia en miocardiopatía diabética.

Asunto(s)

RESUMEN

OBJECTIVES: To establish a relationship between global longitudinal strain (GLS) and Galectin-3 in pre-clinical heart failure in diabetic patients. Galectin-3 is a biomarker in heart failure with depressed ejection fraction (HFdEF). The hypothesis is presented that Galectin-3 is related to GLS and can detect left ventricular dysfunction in heart failure with preserved ejection fraction. METHODS: Galectin-3 and GLS were measured in 121 asymptomatic individuals: 14 diabetics with mild depressed ejection fraction (mdEF) (LVEF 47.0±6.9); 76 diabetics with preserved ejection fraction (LVEF 61±5.5), and 31 controls (61.7±5.1). RESULTS: Galectin-3 was elevated in all diabetics vs controls (3.46±1.36 ng/ml vs 2.78±0.91 ng/ml; p=.003). It was also elevated in mdEF (3.76±1.12 ng/ml vs 2.78±0.9 ng/ml; p=.009) and pEF subjects (3.41±1.40 ng/ml vs 2.78±0.9 ng/ml; p=.058), respectively, vs controls. No difference in Gal-3 was found between diabetic groups (p=.603). Diabetics had lower GLS than controls (-18.5±3.9 vs -20±2.6; p=.022). Diabetics with mdEF had lower GLS than those with pEF (-13.3±3.41 vs -19±3.2; P<.001). There was no difference in GLS with pEF compared to controls (-19.4±3.2 vs -20±2.6; p=.70). CONCLUSIONS: Galectin-3 is elevated in diabetic patients with mdEF, and is associated with a diminished GLS. GLS could be an early marker of left ventricular dysfunction as well as evidence of diabetic cardiomyopathy.

Asunto(s)